Embracing the Patient Voice Within Publications
September 5, 2023 |
This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders.
The biopharmaceutical sector continues to recognize the value of integrating the voice of the patient community into its activities.
Despite growing recognition of the importance of patient partnership within publications, uncertainty remains regarding how best to involve patients and where in the process this involvement should happen. Furthermore, although many of our colleagues working in Medical Affairs and publications have established the goal of engaging patients in publications, possibly as authors, their own internal guidance on publication development may create roadblocks. Compliance and regulatory concerns can limit opportunities to partner with patient communities, and the occasional reluctance of physician authors to include patients as co-authors further exacerbates the situation. Additional barriers arise from the general uncertainty in the scientific communications community as to how and when to engage patients in an appropriate manner that ensures a positive experience and recognizes the resource challenges of advocacy groups.
This paper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders. We recognize that we are all learning together, with the shared goal of evolving our practices to fully embrace the voice of the patient while adhering to publication best practices and compliance. We welcome and encourage feedback from our industry colleagues to further refine our approaches.
This article was originally published in our latest whitepaper “Embracing the Patient Voice Within Publications”. To learn more about the multidisciplinary perspectives on how to better engage patient communities in publications, read the full whitepaper.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Announcing OPEN Health New Communications CEO, Margot Hannah
OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications
OPEN Health Acquires ARK
OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities
Rare thoughts & outcomes – navigating pathways to better outcomes in rare
Mobilizing pathway change – what the past 25 years have shown meWelcome to OPEN Health’s second Rare Thoughts & Outcomes theme for 2021 – Navigating pathways to better outcomes. This…
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)…
Maximize your training investments with learning and development specialists
Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can…
A day in the life of a PR Account Director
We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health
OPEN Health acquires UK medical communications agency Spirit
OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.
OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021
We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).
Pharmerit rebrands to OPEN Health
OPEN Health is moving to one brand to create a world-class integrated services model